Recently, it has been reported that FUNDC2 regulates ferroptosis by interacting with the mitochondrial glutathione transporter SLC25A11 to negatively regulate mitoGSH levels, and that it contributes to doxorubicin (DOX)-induced cardiomyopathy [31]. This evidence concerns the gene FUNDC2 and cardiomyopathy.